Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Graves Diseases - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Graves Diseases (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Graves Diseases and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
49 pages
Pertussis (Whooping Cough) - Pipeline Review, H2 2019
US$ 2,000.00
... . The Pertussis (Whooping Cough) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pertussis (Whooping Cough) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
115 pages
Prosthetic joint infections - Pipeline Review, H2 2019
US$ 2,000.00
... . The Prosthetic joint infections (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Prosthetic joint infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
51 pages
Tinea pedis (Athlete Foot) - Pipeline Review, H2 2019
US$ 2,000.00
... . The Tinea pedis (Athlete Foot) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Tinea pedis (Athlete Foot) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
37 pages
Eastern Equine Encephalitis - Pipeline Review, H2 2019
US$ 2,000.00
Eastern Equine Encephalitis - Pipeline Review, H2 2019 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Eastern Equine Encephalitis - Pipeline Review, H2 2...
December 2019
33 pages
Huntington Disease - Pipeline Review, H2 2019
US$ 2,000.00
Huntington Disease - Pipeline Review, H2 2019 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Huntington Disease - Pipeline Review, H2 2019, provides an o...
December 2019
345 pages
Hypertension - Pipeline Review, H2 2019
US$ 2,500.00
Hypertension - Pipeline Review, H2 2019 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypertension - Pipeline Review, H2 2019, provides an overview of t...
December 2019
699 pages
Multiple Sclerosis - Pipeline Review, H2 2019
US$ 2,500.00
Multiple Sclerosis - Pipeline Review, H2 2019 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Sclerosis - Pipeline Review, H2 2019, provides an o...
December 2019
1019 pages
Progressive Supranuclear Palsy - Pipeline Review, H2 2019
US$ 2,000.00
... . The Progressive Supranuclear Palsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Progressive Supranuclear Palsy and features dormant and discontinued projects. The guide covers therapeutics under Development ...
December 2019
112 pages
Encephalopathy - Pipeline Review, H2 2019
US$ 2,000.00
... . The Encephalopathy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Encephalopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
69 pages
Myocardial Fibrosis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Myocardial Fibrosis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocardial Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
December 2019
89 pages
Dental Pain - Pipeline Review, H2 2019
US$ 2,000.00
... . The Dental Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Dental Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
42 pages
Sepsis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Sepsis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Sepsis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
367 pages
Nicotine Addiction - Pipeline Review, H2 2019
US$ 2,000.00
... . The Nicotine Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Nicotine Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
76 pages
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H2 2019
US$ 2,000.00
... The Coronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Coronary Artery Disease (CAD) (Ischemic Heart Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
November 2019
232 pages
Gorlin Syndrome (Basal Cell Nevus Syndrome) - Pipeline Review, H2 2019
US$ 2,000.00
... . The Gorlin Syndrome (Basal Cell Nevus Syndrome) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Gorlin Syndrome (Basal Cell Nevus Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
148 pages
Scar - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Scar (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Scar and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
75 pages
West Nile Virus Infections - Pipeline Review, H2 2019
US$ 2,000.00
... . The West Nile Virus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for West Nile Virus Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
75 pages
Pseudomonas aeruginosa Infections - Pipeline Review, H2 2019
US$ 2,000.00
... . The Pseudomonas aeruginosa Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pseudomonas aeruginosa Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
282 pages
Atopic Dermatitis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Atopic Dermatitis (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Atopic Dermatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
597 pages
Granulomatosis with Polyangiitis (Wegener Polyangiitis) - Pipeline Review, H2 2019
US$ 2,000.00
... . The Granulomatosis with Polyangiitis (Wegener Polyangiitis) (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Granulomatosis with Polyangiitis (Wegener Polyangiitis) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
November 2019
83 pages
Primary Hyperoxaluria - Pipeline Review, H2 2019
US$ 2,000.00
... And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Primary Hyperoxaluria and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
63 pages
C-X-C Chemokine Receptor Type 2 - Pipeline Review, H2 2019
US$ 3,500.00
... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) development landscape Develop ...
November 2019
69 pages
C-C Chemokine Receptor Type 5 - Pipeline Review, H2 2019
US$ 3,500.00
C-C Chemokine Receptor Type 5 - Pipeline Review, H2 2019 SUMMARY According to the recently published report 'C-C Chemokine Receptor Type 5 - Pipeline Review, H2 2019'; C-C Chemokine Receptor Type 5...
November 2019
90 pages
C-X-C Chemokine Receptor Type 4 - Pipeline Review, H2 2019
US$ 3,500.00
C-X-C Chemokine Receptor Type 4 - Pipeline Review, H2 2019 SUMMARY C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopoly...
November 2019
136 pages
Cytotoxic T Lymphocyte Protein 4 - Pipeline Review, H2 2019
US$ 3,500.00
Cytotoxic T Lymphocyte Protein 4 - Pipeline Review, H2 2019 SUMMARY According to the recently published report 'Cytotoxic T Lymphocyte Protein 4 - Pipeline Review, H2 2019'; Cytotoxic T Lymphocyte P...
November 2019
237 pages
E3 Ubiquitin Protein Ligase XIAP - Pipeline Review, H2 2019
US$ 3,500.00
E3 Ubiquitin Protein Ligase XIAP - Pipeline Review, H2 2019 SUMMARY E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein or Inhibitor Of Apoptosis Protei...
November 2019
83 pages
Ephrin Type B Receptor 4 - Pipeline Review, H2 2019
US$ 3,500.00
Ephrin Type B Receptor 4 - Pipeline Review, H2 2019 SUMMARY Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) pipeline Target constit...
November 2019
45 pages
Nasal Polyps - Pipeline Review, H2 2019
US$ 2,000.00
Nasal Polyps - Pipeline Review, H2 2019 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nasal Polyps - Pipeline Review, H2 2019, provides an overview of t...
November 2019
102 pages
NT 3 Growth Factor Receptor - Pipeline Review, H2 2019
US$ 3,500.00
NT 3 Growth Factor Receptor - Pipeline Review, H2 2019 SUMMARY NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1...
November 2019
74 pages
Prostaglandin D2 Receptor 2 - Pipeline Review, H2 2019
US$ 3,500.00
Prostaglandin D2 Receptor 2 - Pipeline Review, H2 2019 SUMMARY According to the recently published report 'Prostaglandin D2 Receptor 2 - Pipeline Review, H2 2019'; Prostaglandin D2 Receptor 2 (Chemo...
November 2019
61 pages
Retinoic Acid Receptor Alpha - Pipeline Review, H2 2019
US$ 3,500.00
Retinoic Acid Receptor Alpha - Pipeline Review, H2 2019 SUMMARY Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) - Retinoic acid receptor al...
November 2019
68 pages
Retinoic Acid Receptor Beta - Pipeline Review, H2 2019
US$ 3,500.00
Retinoic Acid Receptor Beta - Pipeline Review, H2 2019 SUMMARY According to the recently published report 'Retinoic Acid Receptor Beta - Pipeline Review, H2 2019'; Retinoic Acid Receptor Beta (RAR B...
November 2019
77 pages
Retinoic Acid Receptor Gamma - Pipeline Review, H2 2019
US$ 3,500.00
Retinoic Acid Receptor Gamma - Pipeline Review, H2 2019 SUMMARY Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) pipeline Target constitutes...
November 2019
82 pages
Survival Motor Neuron Protein - Pipeline Review, H2 2019
US$ 3,500.00
Survival Motor Neuron Protein - Pipeline Review, H2 2019 SUMMARY Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Survival of motor neuron or survival motor neuron (S...
November 2019
85 pages
Bronchitis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Bronchitis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Bronchitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
129 pages
Choroidal Neovascularization - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Choroidal Neovascularization (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Choroidal Neovascularization and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
57 pages
